KALINOR

Medicinal product

(Invented) name

KALINOR

Active substance (s)

Kalio citratas/Kalio-vandenilio karbonatas/Citrinų rūgštis

Strength

2,17 g/2 g/2,057 g

Pharmaceutical form

šnypščiosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A12BA02, Potassium citrate

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-06-25

Date of renewal

Documents

2663_KALINOR snypsc_tab_PL_2025-06-25.docx

2663_KALINOR snypsc_tab_PZ_2025-06-25.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Kalio citratas	2,17 g
Kalio-vandenilio karbonatas	2 g
Citrinų rūgštis	2,057 g

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117866	103971	1103971	tūbelė	N15		Receptinis	LT/L/25/2663/001	Netiekiama	-	-	No	-	-	Download
117867	103972	1103972	tūbelė	N30 (2x15)		Receptinis	LT/L/25/2663/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-06-25	Registruotas